RxSight investors may be entitled to compensation through a class action lawsuit.

Rosen Law Firm reminds RxSight investors of the September 22, 2025 lead plaintiff deadline. If you purchased RxSight securities between November 7, 2024 and July 8, 2025, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. To join the class action, visit rosensegal.com/submit-form/?case_id=42362 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information.

NEW YORK, Aug. 9, 2025 — Rosen Law Firm has issued a reminder to investors of RxSight, Inc. (NASDAQ: RXST) regarding an upcoming deadline in a securities class action lawsuit. The firm encourages shareholders who purchased RxSight securities between November 7, 2024, and July 8, 2025, to take action by the September 22, 2025, deadline.

The class action lawsuit alleges that RxSight made materially false and misleading statements during the specified period. According to the complaint, the company failed to disclose significant issues such as adoption challenges, structural problems, and overstated product demand. These omissions led to investors suffering damages when the true details emerged.

Investors are advised to visit [rosenlegal.com/submit-form/?case_id=42362](https://rosenlegal.com/submit-form/?case_id=42362) to join the class action or contact Phillip Kim, Esq., at 866-767-3653 or via email at [case@rosenlegal.com](mailto:case@rosenlegal.com) for more information. The Rosen Law Firm is renowned for its expertise in securities class actions and has recovered hundreds of millions of dollars for investors in the past.

The firm emphasizes the importance of acting promptly to avoid missing the deadline for potential lead plaintiff appointment. The lead plaintiff will represent the class members in directing the litigation, and the Rosen Law Firm assures investors that there is no cost or obligation to participate.

References:
[1] https://www.marketscreener.com/news/rxst-investors-have-opportunity-to-lead-rxsight-inc-securities-fraud-lawsuit-ce7c5ed2d889f722
[2] https://www.globenewswire.com/news-release/2025/08/08/3130291/673/en/ROSEN-TRUSTED-INVESTOR-COUNSEL-Encourages-RxSight-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-RXST.html